I'm raising money for HELP DEB WALK AGAIN. Click to Donate
HIV Infection and AIDS in the Public Health and Health Care Systems
The Role of Law and Litigation
JAMA HIV/AIDS Information Center
Vol. 279, pp. 1108-1113, Apr. 8, 1998
Lawrence O. Gostin, JD; David W. Webber, JD
The AIDS Litigation Project has reviewed nearly 600 reported cases involving individuals with human immunodeficiency virus (HIV) infection and acquired immunodeficiency syndrome (AIDS) in the federal and state courts in the United States between 1991 and 1997. Cases were identified through a federal and 50-state computer and library search. An important subset of litigation relates to HIV/AIDS in the public health and health care systems, since the law affects health care institutions and professionals, patients, and public health policy in America. This subset of HIV/AIDS litigation includes testing and reporting; privacy, the duty to warn, and the right to know; physician standards of care in prevention and treatment; and discrimination and access to health care. In broad terms, the review demonstrates a reliance on voluntary testing and protection of patient privacy through HIV-specific statutes and the common law. Negligence with potential civil and criminal liability has been alleged in cases of erroneous or missed diagnosis of HIV infection. In the first AIDS case to be considered by the Supreme Court, the Court will decide whether patients with asymptomatic HIV infection are protected under the Americans With Disabilities Act. Considerable progress has been made, both socially and legally, during the first 2 decades of the epidemic, but much still needs to be accomplished to protect privacy, prevent discrimination, and promote tolerance.
Editor's Note: For a comprehensive report on the AIDS Litigation Project, see 2 articles from the AIDS & Public Policy Journal that are available in full text on this site with the kind permission of that journal's publisher. The articles analyze cases involving the duties of government and individuals in preventing HIV transmission (Part I), as well as those involving the rights of individuals (Part II).
THE EPIDEMIC of human immunodeficiency virus (HIV) infection and the acquired immunodeficiency syndrome (AIDS) has had powerful personal, social, and economic effects throughout America—in employment, housing, insurance, education, prisons, and many other aspects of life. Yet, perhaps the most profound effects of the epidemic have been in the public health and health care systems. Public health and medicine have responsibilities to monitor, prevent, and treat HIV infection. At the same time, the nation has struggled with the task of reconciling patients' rights to privacy and nondiscrimination with collective rights to public health protection.
Given the high degree of ongoing social conflict caused by the epidemic, it is not surprising that, unlike past infectious disease outbreaks, attempts to resolve contentious issues consistently involve the courts and legislatures at all levels. Furthermore, because of the high level of patient activism and advocacy, as well as immediate public access to new developments in scientific and medical information, including that available via the Internet, law and policymaking have not been the exclusive preserve of medical experts or other professional specialists. The resulting democratization of policymaking processes has heightened the impact that legislatures and courts have had on the public health and health care systems.
Deeply divisive questions have emerged relating to informed consent for HIV testing, named HIV reporting, confidentiality vs the duty to warn, and an HIV-infected physician's right to practice. These and many other questions have come to be decided by legislatures and courts. The results are by no means uniform or consistent. Court decisions in similar cases sometimes conflict, and legislatures in different jurisdictions at times take markedly different approaches. Nevertheless, legislation and litigation provide a window through which the HIV epidemic's troubling questions, arising in relation to the delivery of health care services and the formulation of complex public health policy, can be examined.
This article is part of the AIDS Litigation Project,[3,4] which has reviewed nearly 600 cases reported in the federal and state courts in the United States between 1991 and 1997. The methods involved a federal and 50-state computer and library search of all reported cases involving HIV infection or AIDS. This article discusses an important subset of litigation relating to HIV/AIDS in the public health and health care systems. (The complete AIDS Litigation Project report can be found in the Library section of the HIV/AIDS Information Center at http://www.ama-assn.org.)
IDENTIFYING CASES OF HIV INFECTION: TESTING AND REPORTING
Issues of law and public policy take on new urgency as the HIV/AIDS epidemic experiences a paradigm shift. Combination antiviral therapies and clinical prophylaxes provide for the first time an opportunity for a longer, higher quality of life for persons living with HIV. Combination therapies have markedly reduced the incidence of AIDS, have lowered rates of perinatal transmission,[7,8] and potentially may diminish infectiousness by decreasing viral load. With these new treatment opportunities, it becomes critically important to identify persons at the earliest stages of HIV infection and to ensure full and fair access to the health care system.
Testing, since the approval of an HIV antibody test in early 1985, has been considered essential for HIV prevention. With more recent advances in antiviral and prophylactic treatments, testing has also become important as an entree into the health care system. Public health and medical authorities recommend that all persons at risk should know their serologic status, and many want to see the "routinization" of HIV testing. A broad range of testing services are desirable, such as testing by primary care clinicians and hospitals, public clinics, "alternative" (anonymous) test sites, and home testing. The technological development of "rapid" tests and analyses of saliva and urine will make testing easier for the public.
Despite the manifest clinical and public health benefits, testing may result in loss of privacy, increased social stigma, and discrimination. As a result, many state legislatures have enacted special requirements for HIV testing. State legislation requires informed consent, often in writing, as well as pretest and posttest counseling. While counseling and consent are thought to be important to enhance patient autonomy, ironically, they do make it more burdensome for health care professionals to "routinize" HIV testing and bring it into the mainstream of medicine.
Voluntary testing is almost universally recommended, and most states have abided by an ethic of voluntarism. Compulsory, nonconsensual testing has been undertaken only in limited circumstances and principally for nonmedical purposes. Thus, mandatory tests are imposed, for example, on US military and foreign service personnel, immigrants, and certain sex offenders.[13,14] In the health care setting, however, compulsory testing violates statutory and common law requirements for informed consent and may violate nondiscrimination statutes or constitutional prohibitions against unreasonable searches and seizures. Although a Pennsylvania court held that HIV testing without patient consent or knowledge did not violate state common law doctrines of informed consent or invasion of privacy, that ruling was subsequently overturned by statute.
Some states permit nonconsensual HIV testing of patients in limited circumstances. An Alabama statute, for example, allows testing without consent if (1) the patient is at "high risk" of infection; (2) knowledge of the patient's serologic status is necessary for medical care; or (3) knowledge of HIV status is needed for the protection of health care personnel. A federal district court found the high-risk classification to be unconstitutional because a patient could be arbitrarily classified, but upheld the other 2 classifications. Many states allow compulsory testing to determine the HIV status of a patient in the event of an injury to a health care worker, emergency response employee, or corrections officer that poses a risk of HIV transmission.
Scientific evidence that anti-HIV therapy could significantly reduce perinatal transmission, together with new treatment opportunities for newborns, has led legislatures to consider mandatory testing of pregnant women and newborn infants. Under federal law, states must at a minimum follow Centers for Disease Control and Prevention (CDC) guidelines recommending counseling and voluntary testing for all pregnant women. If federally set targets for reduction of perinatal HIV transmission are not met, mandatory measures ensue. At the state level, several legislatures have enacted laws that mandate counseling and make voluntary testing available. These federal and state statutes may set a standard of care in tort, so that failure to counsel and offer testing to pregnant women may result in physician liability for wrongful life or wrongful birth in the event that the infant is born with HIV infection. New York has enacted a law requiring mandatory testing of newborns, even though a positive antibody test reveals the serologic status of the mother. New York's law also requires disclosure to the mother and protects confidentiality. That law is currently under court challenge on constitutional grounds.
Since the earliest moments of the epidemic, all states have required named reporting of CDC-defined AIDS. By contrast, 28 states require HIV reporting, and 3 additional states conduct HIV surveillance for pediatric cases only. All HIV reporting states except Maryland and Texas are name based. The CDC recently recommended that all states move to a system of HIV surveillance. The CDC also recommends that states (unless otherwise required by state law) provide alternative test sites where names of persons with HIV infection are not reportable. Ten states proscribe nonreportable, anonymous testing. North Carolina's closure of publicly funded anonymous HIV test sites was upheld as a valid exercise of the state's public health powers.
The predominantly voluntary approach to HIV testing and the absence of a national HIV surveillance system has resulted in concerns that HIV/AIDS has acquired a special or "exceptional" status. In New York State, prominent medical organizations sued to compel the health commissioner to include HIV in the official list of sexually transmitted diseases (STDs). By failing to classify HIV as an STD, the commissioner declined to trigger his powers for compulsory testing, reporting, and contact tracing. New York's highest court held that the classification of diseases was within the commissioner's discretion and affirmed the reasonableness of his belief that the exercise of mandatory powers would not serve an important public health purpose.
PRIVACY, DUTY TO WARN, AND THE RIGHT TO KNOW
Privacy of HIV data has been thought to be necessary for both patient autonomy and public health. Privacy safeguards against social stigma and discrimination and allows each person to make decisions for herself concerning disclosure. Privacy also supports trusting clinical relationships and participation in public health services such as testing, counseling, and partner notification. Most states have HIV-specific statutes requiring confidentiality of HIV data. Litigation claiming wrongful disclosure of HIV-related information has been commenced against numerous individual and institutional providers during the course of the epidemic, including hospitals, physicians, and health departments.
Guided by the mandates of the provider-patient privilege and state HIV confidentiality laws, health care professionals are generally prohibited from revealing a patient's HIV-related information. In fact, some state privacy statutes specifically protect HIV information within the health care or social service setting. Intentional disclosure is only 1 way to breach confidentiality. A health care facility's negligent failure to protect a medical record from disclosure may also violate privacy. However, not all disclosures result in liability. If the health care provider can present a compelling reason for disclosure, a court may allow it. The courts balance the need for the disclosure against the harm done to both the individual's privacy and the public interest and often have little difficulty finding against the individual's privacy right. Using such a test, a Pennsylvania court authorized a hospital to disclose a physician's HIV status to 280 patients who had received invasive procedures. In another case, a court held that a public health agency's disclosure of confidential HIV information to aid in a criminal prosecution was permissible; the criminal activity was deemed a waiver of confidentiality. In contrast, another court prohibited law enforcement access to public health records.
A major tension exists between confidentiality and the "right to know." Health care workers and others who perceive themselves to be at risk for HIV infection in the workplace claim the right to know the HIV status of patients or others. Generally, because infection control precautions in the health care setting are both the standard of practice and highly effective, right-to-know claims are difficult to maintain. For example, a surgeon's lawsuit alleging emotional distress caused by learning, after the fact, that his surgical patient was HIV positive was rejected. Similarly, if morticians and emergency response employees use universal infection control precautions, the risk of HIV transmission is negligible. Nevertheless, federal law authorizes, under certain circumstances, disclosure of HIV information to morticians and emergency response workers upon their request. But whether right-to-know claims will be successful in generating damage awards seems questionable. In a West Virginia case, a mortician filed a tort action against a hospital for failing to inform him that a corpse he had handled was contaminated with HIV. The court found no liability in the absence of actual exposure.
Fear of HIV Exposure in the Health Care Setting
Many cases have been filed by patients claiming that individual or institutional health care providers are liable for exposing them to the risk of HIV transmission without their knowledge. Patients argue that health care professionals negligently caused them emotional distress by failing to warn or failing to prevent some contact that is perceived to pose a risk of transmission. These plaintiffs seek compensation for their mental distress and anguish. Recognizing the litigious nature of American society, many courts limit fear of HIV claims by requiring proof that the plaintiff's mental distress is a result of circumstances posing an actual risk of HIV transmission. Plaintiffs who fear an objectively nonexistent or unprovable risk generally will not be compensated.[45,46] Furthermore, many courts limit compensation to distress occurring during the "window of anxiety," the period between learning of possible exposure and obtaining a reliable HIV-negative test result. In 1 case, a surgical patient provided her own blood for transfusion, but the surgeon transfused another donor's blood. This negligence caused emotional distress that, in light of plaintiff's precautions, was in the court's view both reasonable and foreseeable.
HIV-Infected Health Care Professional's Duty to Disclose
Several courts have held that health care professionals have a duty to disclose their HIV status to patients or health authorities, assuming that their professional activities pose a risk of transmission to patients. The Maryland Court of Appeals ruled that a surgeon has a duty to inform his patients of his infection; even if the patient has not actually been exposed and tests HIV negative, the contact with the surgeon may subsequently give rise to a claim for the infliction of mental distress due to fear of transmission. Courts justify orders to disclose based on a duty to protect patients and on the doctrine of informed consent. Requiring disclosure to patients, of course, can severely jeopardize a health care professional's career. To avoid this result, some states allow the professional to continue practicing, with appropriate restrictions and supervision, but without disclosing his or her HIV status.
The Duty to Warn Third Parties at Risk
Many state laws permit, but do not require, disclosure by physicians to third parties known to be at significant future risk of HIV transmission from patients known to be infected. Thus, if a physician reasonably believes that a patient will share drug injection equipment or have unprotected sex without informing a partner of the risk, the physician has discretion to inform the partner. Under some disclosure laws, the physician is required to first counsel the patient to refrain from the risk behavior, and, in providing the third-party warning, the physician is prohibited from disclosing the patient's identity. In the absence of state laws permitting such disclosure, physicians may be held liable for breach of confidentiality for disclosing patient information to sex partners.
The "duty to warn" may extend to nonpatient third parties in other contexts, based on the provider's primary duty to the patient. Thus, health care professionals have a duty to inform patients that they have been transfused with HIV-contaminated blood, and this duty may extend to third parties. A physician in 1 case failed to inform a teenager or her parents that she had been transfused with HIV-contaminated blood. When the young woman's sexual partner tested positive for HIV, the court upheld his claim against the physician based on the physician's failure to inform the patient. Similarly, courts have held that a health care professional's duty to inform a patient of his or her HIV infection may extend to those the patient foreseeably puts at risk such as a spouse or family member caregiver. On the other hand, courts have ruled that disclosure is wrongful in cases in which the third party, such as a family member, is not at actual risk of infection, or the physician has no knowledge that the patient has failed to disclose to the partner.
PREVENTION AND TREATMENT: PHYSICIAN STANDARDS OF CARE
Negligent Diagnosis of HIV/AIDS
Patients who have been erroneously informed that they are HIV-infected, when in fact they are not, have filed suit against their health care providers for negligent infliction of emotional distress. Some of these plaintiffs have argued that an HIV-positive diagnosis is a "death sentence" that inflicts extreme psychological harm. To limit recovery to only those cases involving a significant claim for compensation, some courts have refused to award damages unless the mental distress arose from or led to physical injury. For example, courts have held that increased blood pressure is not an adequate injury, but that adverse effects of AIDS treatments or a patient's attempt at suicide would suffice to justify liability. Other courts have not imposed a physical injury requirement.
Providers may also be liable for negligently failing to diagnose HIV infection. In 1 case, a jury awarded more than $1 million in a case in which an earlier diagnosis would have delayed by 1 year the onset of symptoms, disability, and death. A physician may also be liable for unnecessary delay in notifying a patient of exposure to HIV and may be liable to the patient's sexual partner who is subsequently infected. However, providers have not been held liable for failure to diagnose and effectively treat HIV unless the plaintiff has shown a causal connection between their failure and the injury suffered. In the early years of the epidemic, failure to diagnose HIV infection did not expose the provider to significant liability, since treatment options and likelihood of success in treatment were limited. But as treatments for HIV illness develop to higher levels of efficacy, failure to render a prompt diagnosis or failure to initiate prompt and appropriate treatment may expose providers to increasing liability.
Distribution of Drug Injection Equipment
Public health and medical authorities recommend that physicians counsel drug users to use a new syringe and needle for every injection. Syringe exchanges have been established at the state and local levels to prevent transmission of HIV and other blood-borne pathogens. Nevertheless, a web of state statutes create criminal offenses for the sale, distribution, or possession of syringes and needles.[64,65] These laws pose the threat of prosecution to public health officials and community activists who distribute sterile needles and syringes, and, in some cases, prosecutions have resulted. The Washington Supreme Court, however, upheld syringe exchange as a valid public health measure. The court reasoned that the health department had acted in pursuance of an AIDS statute that granted the department the general power to implement prevention strategies. Federal law prohibits use of federal funds for syringe exchange until the secretary of health and human services certifies that exchanges are effective in preventing HIV infection and do not encourage drug use.
DISCRIMINATION AND ACCESS TO CARE
The HIV epidemic has been characterized by a high level of social opprobrium against those infected or suspected of being infected. As a result, individuals with HIV infection routinely encounter discrimination in many aspects of their lives. Discrimination in the health care setting, however, is especially pernicious, depriving patients of necessary services and undermining their trust in the system's commitment to provide them with the care they need. If individuals fear discrimination in health care, they may forgo testing or fail to discuss their health and risk behaviors. Furthermore, because health care professionals are viewed by the general public as being well informed, their actions set a poor example for others attempting to respond to the epidemic in a nondiscriminatory fashion.
Institutional health care providers and other employers have a duty to provide a reasonably safe workplace. The use of barrier techniques on a universal basis has been the officially sanctioned approach to workplace safety. As a result, discrimination against patients is rarely, if ever, justified by a provider's fear of transmission. The Occupational Safety and Health Administration's (OSHA's) blood-borne pathogen safety standard has been challenged as overly broad, but remains the primary safety standard. Although employer noncompliance with infection control standards may give rise to a justifiable refusal to work, the underlying fear must have an objective basis. Employee claims of occupational transmission (or fear of occupational transmission) are generally covered by worker compensation statutes, which provide exclusive remedies for work-related claims against employers.
Definition of "Disability" Under the ADA: The Supreme Court's First AIDS Case
An array of laws at the federal, state, and local levels prohibit discrimination on the basis of a person's disability or health status. The primary federal nondiscrimination statute is the Americans With Disabilities Act (ADA) of 1990,[73,74] although the laws of many states and localities also specifically prohibit discrimination against individuals living with HIV/AIDS.
The ADA provides that no individual "shall be discriminated against on the basis of disability in the full and equal enjoyment of the goods, services, facilities, privileges, advantages, or accommodations of any place of public accommodation." The ADA's definition of "public accommodation" specifically includes hospitals and professional offices of health care providers. Similarly, New York's highest court ruled that the offices of private dentists are considered places of public accommodation under New York law.
A critically important issue under the ADA is whether persons with asymptomatic HIV infection have a "disability" and thus are protected under the ADA. Disability is defined as a physical or mental impairment that substantially limits 1 or more of the major life activities of the individual, a record of such impairment, or being regarded as having such an impairment. In the past, many courts have ruled or assumed as undisputed that HIV infection, as the underlying cause of a life-threatening illness, is a disability. However, several recent court decisions have held that HIV does not automatically qualify as a disability, and in each case there must be an individualized determination as to whether the infection actually limits, in a substantial way, a major life activity. Given the advent of new combination therapies that significantly delay the onset of disabling symptoms, this judicial view could markedly undermine legal protection against discrimination for persons with asymptomatic or mildly symptomatic HIV infection. The ADA's legislative history, however, indicates that Congress intended to include HIV infection within the definition of disability, and the Equal Employment Opportunity Commission's regulations embody that view. In its first AIDS case ever, the Supreme Court will decide whether and to what extent persons with HIV infection are protected under the ADA.
In Abbott v Bragdon, a dentist refused to fill a dental cavity of an HIV-infected patient. The patient then brought suit alleging that the refusal violated the ADA. The dentist conceded that his professional office was covered by the ADA, but argued that providing services to the infected patient, because of the risk of HIV transmission, would pose a direct threat to his health. Additionally, he argued that the plaintiff, who did not have symptoms of HIV illness, was not an individual with a disability under the ADA. The lower courts rejected the dentist's defenses, concluding that the dentist was unable to show that in 1994, when the case arose, there was evidence that treating an infected patient posed a significant risk. The plaintiff's infection, which she testified resulted in her decision against becoming pregnant, was viewed as substantially limiting the major life activity of reproduction. The Supreme Court has agreed to consider 3 questions presented by the case: (1) whether reproduction is a major life activity; (2) whether asymptomatic HIV infection is a per se disability under the ADA; and (3) whether the courts should defer to a health care provider's reasonable professional judgment.
The ADA's coverage also extends to individuals merely regarded as having a disability. Thus, it is unlawful to discriminate against an individual based on the misperception that the person is infected with HIV under the ADA as well as under the laws of many states. Persons discriminated against because of their association with a person with HIV infection are also protected, as are persons retaliated against because of their opposition to discrimination.
The Health Care Professional's Duty to Treat
Courts have consistently held that health care professionals have a legal duty to treat patients living with HIV/AIDS. Health care professionals must, of course, exercise appropriate clinical judgment. If a professional lacks the skill appropriate to render competent care, she may legally refuse to treat the person and may lawfully refer him elsewhere. A clinician cannot, however, simply reject or refer an HIV-infected patient solely because of his or her HIV status.
The courts have had to decide the difficult question whether and to what degree a health care professional can treat HIV-infected persons differently from other patients. Although CDC and OSHA standards require use of "universal" precautions applicable to all patients without regard to infection status, imposition of special precautions for HIV-infected patients has been upheld. One court, finding that special precautions may be necessary for certain procedures, ruled that a dentist may lawfully refuse to treat a patient who refuses to reveal HIV-related information. But another court ruled that the use of special precautions, which resulted in delay of services, beyond those recommended by the CDC constituted unlawful discrimination.
Nondiscrimination in Health Insurance
Access to health care is often contingent on the ability to pay or the availability of insurance coverage. Federal and state law provides little or no protection from adverse coverage decisions provided the insurance company uses sound actuarial data. However, an employer's decision to place severe limits on coverage for HIV/AIDS, but not on comparable diseases, may be unlawful under the ADA.[90,91] A central question in determining the extent of health insurance coverage is whether certain services are "medically necessary." In an important case, the Eleventh Circuit Court of Appeals held that skilled nursing care was "medically necessary" and should be reimbursed under an employer's self-funded health benefits plan.
HIV-Infected Health Care Professionals
Federal law requires states to comply with CDC guidance that recommends an individualized determination of whether HIV-infected physicians engaging in "exposure-prone" procedures can safely practice. At present the CDC and the American Medical Association are reevaluating their policies in light of epidemiologic evidence showing that the risk to patients, even from invasive procedures, is negligible. The judiciary has had to decide whether HIV-infected health care professionals pose a significant risk to their patients, and thus are not qualified to continue to practice. Several courts have upheld decisions to prohibit HIV-infected health care professionals who perform invasive procedures.[95,96] These courts have reasoned that the severity of harm if HIV infection were transmitted justifies practice restrictions. However, the Ninth Circuit Court of Appeals held that a physician's practice could not be restricted if he did not primarily perform invasive procedures. The physician, a general internist, was employed by the Federal Bureau of Investigation (FBI). The agency refused to refer patients to the physician after suspecting that he was HIV positive. The court ruled that the FBI had failed to make adequate inquiries about the physician's infection control procedures: "The record shows that Dr. Doe and the hospital were entirely forthcoming about these procedures, but that their explanations fell on deaf ears."
Prisoner Health Care
Access to adequate health care for prison inmates living with HIV/AIDS has been a long-term problem. Gross inadequacies in state prison health care systems may rise to a constitutional violation. In New York, inmates living with HIV/AIDS challenged the state's delivery of medical, mental health, educational, and prevention services. The court ordered the state to release records enumerating the inmates, both living and deceased, who had been diagnosed as having AIDS or AIDS-related illnesses, in order to aid in the court's determination as to whether the prison authorities deliberately neglected the inmates' health care needs. Inadequate medical care and lack of HIV education services resulted in a court-imposed remedial plan in another case. But when a showing of deliberate indifference is lacking, federal constitutional claims against prison officials will fail.
Considerable progress has been made—socially and legally—during the first 2 decades of the HIV/AIDS epidemic. Reductions in social stigma and new statutes to protect privacy and proscribe discrimination have emerged. The serious consequences of the epidemic, however, are not over. While instances of gross abuse are less frequent, intolerance and animus stubbornly persist. Even legal advances have been eroded with some courts denying antidiscrimination protection for persons with asymptomatic HIV infection, and upholding discrimination against HIV-infected health care professionals despite the extremely low risks.
Systematic efforts to confront the HIV/AIDS epidemic are needed: (1) expanded and nondiscriminatory access to health care; (2) expansion of counseling, testing, and other prevention services; (3) educational campaigns to promote tolerance and reduce social stigma; and (4) better laws to protect privacy and prohibit discrimination. The health care and public health systems need these and other kinds of new strategies to reduce the deep personal and social burdens of HIV disease in the United States.
From the Georgetown/Johns Hopkins Program on Law and Public Health, Washington, DC, and Baltimore, Md (Mr Gostin). Mr Webber is in private practice in Philadelphia, Pa.
Reprints: Lawrence O. Gostin, JD, Georgetown University Law Center, 600 New Jersey Ave NW, Washington, DC 20001 (e-mail: firstname.lastname@example.org).
Health Law and Ethics section editors: Lawrence O. Gostin, JD, the Georgetown/Johns Hopkins University Program on Law and Public Health, Washington, DC, and Baltimore, Md; Helene M. Cole, MD, Contributing Editor, JAMA.
1. Webber DW, ed. AIDS and the Law. 3rd ed. New York, NY: John Wiley & Sons Inc; 1997.
2. Gostin LO, ed. AIDS and the Health Care System. New Haven, Conn: Yale University Press; 1990.
3. Gostin LO. The AIDS Litigation Project: a national review of court and Human Rights Commission decisions, I: the social impact of AIDS. JAMA. 1990;263:1961-1970.
4. Gostin LO. The AIDS Litigation Project: a national review of court and Human Rights Commission decisions, II: discrimination in education, employment, housing, insurance, and health care. JAMA. 1990;263:2086-2093.
5. Carpenter CCJ, Fischl MA, Hammer SM, et al. Antiretroviral therapy for HIV infection in 1997. JAMA. 1997;277:1962-1969.
6. Centers for Disease Control and Prevention. Update: trends in AIDS incidence—United States, 1996. MMWR Morb Mortal Wkly Rep. 1997;46:861-867.
7. Peckham C, Gibb D. Mother-to-child transmission of the human immunodeficiency virus. N Engl J Med. 1995;333:298-302.
8. Fiscus SA, Adimora AA, Schoenbach VJ, et al. Perinatal HIV infection and the effect of zidovudine therapy on transmission in rural and urban counties. JAMA. 1996;275:1483-1494.
9. Centers for Disease Control. Provisional Public Health Service interagency recommendations for screening donated blood and plasma for antibody to the virus causing acquired immunodeficiency syndrome. MMWR Morb Mortal Wkly Rep. 1985;34:1-5.
10. 32 CFR §§58.1-58.6 (1997).
11. American Fed'n of Gov't Employees, Local 1812 v US Dep't of State, 662 F Supp 50 (DDC 1987).
12. Gostin LO, Cleary PD, Mayer K, Brandt A, Chittenden E. Screening and exclusion of international travelers and immigrants for public health purposes: an evaluation of United States policy. N Engl J Med. 1990;322:1743-1746.
13. US v Ward, 131 F3d 335 (3d Cir 1997).
14. Gostin LO, Lazzarini Z, Alexander DD, et al. HIV testing, counseling, and prophylaxis after sexual assault. JAMA. 1994;271:1436-1444.
15. T.E.P. v Leavitt, 840 F Supp 110 (D Utah 1993).
16. Glover v Eastern Neb Community Office of Retardation, 686 F Supp 243 (D Neb 1988), aff'd, 867 F2d 461 (8th Cir), cert denied, 493 US 932 (1989).
17. Doe v Dyer-Goode, 566 A2d 889 (Pa Super Ct 1989).
18. Pa Stat Ann tit 35, §7607.
19. Hill v Evans, No. 91-A-626-N, 1993 WL 595676 (MD Ala Oct 7, 1993).
20. 42 USC §300ff-34.
21. Anastosopoulos v Perakis, 644 A2d 480 (Me 1994).
22. New York Department of Health, Maternal-Pediatric HIV Prevention and Care Program. HIV Counseling and Testing of Newborns as Part of the Comprehensive Newborn Testing Program. Albany: New York Dept of Health Maternal-Pediatric HIV Prevention and Care Program; 1997. Memorandum 97-2.
23. R.Z. v Pataki, Index No. 97-112960 (Sup Ct NY County, complaint filed July 18, 1997).
24. Alabama, Arizona, Arkansas, Colorado, Florida, Idaho, Indiana, Louisiana, Michigan, Minnesota, Mississippi, Missouri, Nebraska, Nevada, New Jersey, New Mexico, North Carolina, North Dakota, Ohio, Oklahoma, South Carolina, South Dakota, Tennessee, Utah, Virginia, West Virginia, Wisconsin, Wyoming.
25. Connecticut, Texas, and Oregon.
26. Gostin LO, Ward JW, Baker, AC. National HIV case reporting for the United States. N Engl J Med. 1997;337:1162-1167.
27. Alabama, Idaho, Michigan, Nevada, North Carolina, Ohio, South Carolina, South Dakota, Tennessee, and Wyoming.
28. ACT-UP Triangle v Comm'n for Health Servs, 483 SE2d 388 (NC 1997), rev'g 472 SE2d 605 (NC Ct App 1996).
29. Bayer R. Public health policy and the AIDS epidemic: an end to HIV exceptionalism. N Engl J Med. 1991;324:1500-1503.
30. New York State Soc'y of Surgeons v Axelrod, 572 NE2d 605 (NY 1991).
31. Report of the Presidential Commission on the Human Immunodeficiency Virus Epidemic. Washington, DC: US Government Printing Office; 1988.
32. Gostin LO, Lazzarini Z, Neslund VS, et al. The public health information infrastructure: a national review of the law on health information privacy. JAMA. 1996;275:1921-1927.
33. Doe v Methodist Hosp, 639 NE2d 683 (Ind Ct App 1994).
34. Doe v Marselle, 675 A2d 835 (Conn 1996), rev'g 660 A2d 871(Conn App Ct 1995).
35. Estate of Benson v Minnesota Bd of Medical Practice, 526 NW2d 634 (Minn Ct App 1995).
36. Doe v Roe, 588 NYS2d 236 (Sup Ct Onondaga County 1992), rev'd in part, 599 NYS2d 350 (App Div 1993), subsequent opinion, 620 NYS2d 666 (App Div 1994).
37. NY Pub Health Law §2782.
38. Estate of Behringer v Medical Ctr, 592 A2d 1251 (NJ Super Ct Law Div 1991).
39. In re Milton S. Hershey Medical Ctr, 634 A2d 159 (Pa 1993), aff'g 595 A2d 1290 (Pa Super Ct 1991).
40. State v Stark, 832 P2d 109 (Wash Ct App 1992).
41. State v J. E., 606 A2d 1160 (NJ Super Ct Law Div 1992).
42. Ordway v County of Suffolk, 583 NYS2d 1014 (Sup Ct Suffolk County 1992).
43. 42 USC §300ff-76(4).
44. Funeral Servs by Gregory, Inc v Bluefield Community Hosp, 413 SE2d 79 (WVa 1991), overruled in part by Courtney v Courtney, 437 SE2d 436 (WVa 1993).
45. Kaufman v Physical Measurements, Inc, 615 NYS2d 508 (App Div 1994).
46. Barrett v Danbury Hosp, 654 A2d 748 (Conn 1995).
47. Madrid v Lincoln County Medical Ctr, 923 P2d 1154 (NM 1996), aff'g 909 P2d 14 (NM Ct App 1995).
48. Hoffman v Brandywine Hosp, 661 A2d 397 (Pa Super Ct 1995).
49. Faya v Almaraz, 620 A2d 327 (Md 1993).
50. Gostin LO, Hodge J. Piercing the veil of secrecy in HIV/AIDS and other sexually transmitted diseases: theories of privacy and disclosure in partner notification: contact tracing, the "right to know," and the "duty to warn." Duke J Gender Law & Policy. In press.
51. N. O. L. v District of Columbia, 674 A2d 498 (DC 1996).
52. Reisner v Regents of Univ of Cal, 37 Cal Rptr 2d 518 (Ct App 1995).
53. Garcia v Santa Rosa Health Care Corp, No. 13-94-482-CV, 1996 Tex App LEXIS 824 (Tex App 13 Dist 1996), substituted opinion upon reh'g, 1996 Tex App LEXIS 2513 (Tex App 13 Dist June 20, 1996).
54. J. B. v Sacred Heart Hosp, 635 So2d 945 (Fla 1994), certified question at 996 F2d 276 (11th Cir 1993).
55. Diaz Reyes v US, 770 F Supp 58 (DPR 1991), aff'd without opinion, 971 F2d 744 (1st Cir), cert denied, 504 US 957 (1992).
56. R. J. v Humana of Fla, Inc, 652 So2d 360 (Fla 1995).
57. Bramer v Dotson, 437 SE2d 773 (WVa 1993).
58. Doe v McNulty, 630 So2d 825 (La Ct App 1993), cert denied, 631 So2d 1167 (La 1994).
59. Mixon v Cason, 622 So2d 825 (Ala 1993).
60. Baker v English, 894 P2d 505 (Ore Ct App 1995), aff'd in part & rev'd in part, 932 P2d 57 (Ore 1997).
61. Centers for Disease Control and Prevention. HIV Prevention Bulletin: Medical Advice for Persons Who Inject Illicit Drugs. Atlanta, Ga: Centers for Disease Control and Prevention; May 9, 1997.
62. Normand J, Vlahov D, Moses LE, eds. Preventing HIV Transmission: The Role of Sterile Needles and Bleach. Washington, DC: National Academy Press; 1995.
63. Burris S, Finucane D, Gallagher H, Grace J. The legal strategies used in operating syringe exchange programs in the United States. Am J Public Health. 1996;86:1161-1166.
64. Gostin LO, Lazzarini Z, Jones TS, et al. Prevention of HIV/AIDS and other blood-borne diseases among injection drug users: a national survey on the regulation of syringes and needles . JAMA. 1997; 277:53-62.
65. Gostin LO, Lazzarini Z. Prevention of HIV/AIDS among injection drug users: the theory and science of public health and criminal justice approaches to disease prevention. Emory Law J. 1997;46:587-696.
66. Spokane County Health Dist v Brockett, 839 P2d 324 (Wash 1992).
67. Pub L No. 105-78, Title V, §§505-506, 1997 USCCAN (111 Stat) 1467, 1515.
68. Occupational Safety and Health Administration. Blood borne pathogens. 29 CFR §1910.1030 (1997).
69. American Dental Ass'n v Martin, 984 F2d 823 (7th Cir 1993).
70. Armstrong v Flowers Hosp, 33 F3d 1308 (11th Cir 1994), aff'g 812 F Supp 1183 (MD Ala 1993).
71. Miller P, Tereskerz D, Jagger J. Occupationally acquired HIV. Am J Public Health. 1997;87:1558-1562.
72. Elliott v Dugger, 579 So2d 827 (Fla Dist Ct App 1991), prior opinion, 542 So2d 392 (Fla Dist Ct App 1989).
73. 42 USC §§12101 et seq.
74. Gostin L, Beyer H, eds. The Americans With Disabilities Act: What It Means for All Americans. Baltimore, Md: Brookes Publishing Co; 1993.
75. 42 USC §12182(a).
76. 42 USC §12181(7).
77. Cahill v Rosa, 674 NE2d 274 (NY 1996), rev'g 632 NYS2d 614 (App Div 1995).
78. Parmet WE, Jackson DH. No longer disabled: the legal impact of the new social construction of HIV. Am J Law Med. 1997;23:7-44.
79. 42 USC §12102(2).
80. 29 CFR §1630, appendix at 339 (1996).
81. Abbott v Bragdon, 107 F3d 934 (1st Cir 1997), aff'g 912 F Supp 580 (D Me 1995), cert granted, 118 SCt 554 (1997).
82. Sanchez v Lagoudakis, 486 NW2d 657 (Mich 1992), subsequent opinion, 552 NW2d 472 (Mich Ct App 1996).
83. Finley v Giacobbe, 827 F Supp 215 (SD NY 1993).
84. Sherer v Foodmaker, Inc, 921 F Supp 651 (ED Mo 1996).
85. Howe v Hull, 873 F Supp 72 (ND Ohio 1994).
86. Schulman v State Div of Human Rights, 641 NYS2d 134 (App Div 1996), rev'd, 677 NE2d 284 (NY 1997), on remand, 658 NYS2d 70 (App Div 1997).
87. North Shore Univ Hosp v Rosa, 657 NE2d 483 (NY 1995), aff'g 600 NYS2d 90 (App Div 1993).
88. Doe v Kahala Dental Group, 808 P2d 1276 (Haw), reconsideration denied, 841 P2d 1074 (Haw 1991).
89. Sharrow v Bailey, 910 F Supp 187 (MD Pa 1995).
90. EEOC Interim Guidance on Application of the ADA to Health Insurance. Washington, DC: Equal Employment Opportunities Commission; June 8, 1993.
91. Carparts Distrib Ctr, Inc v Automotive Wholesalers Ass'n, 37 F3d 12 (1st Cir 1994), rev'g 826 F Supp 583 (D NH 1993).
92. Florence Nightingale Nursing Serv v Blue Cross & Blue Shield, 832 F Supp 1456 (ND Ala 1993), aff'd, 41 F3d 1476 (11th Cir), cert denied, 115 S Ct 2002 (1995).
93. Pub L No. 102-141, Title VI, §633, 1991 USCCAN (105 Stat) 834, 876-77, reprinted in note to 42 USC §300ee-2.
94. Centers for Disease Control and Prevention. Recommendations for preventing transmission of human immunodeficiency virus and hepatitis B virus to patients during exposure-prone invasive procedures. MMWR Morb Mortal Wkly Rep. 1991;40(RR-8):1-9.
95. Bradley v Univ of Tex M. D. Anderson Cancer Ctr, 3 F3d 922 (5th Cir 1993) (per curiam), cert denied, 114 SCt 1071 (1994).
96. Mauro v Borgess Medical Ctr, 886 F Supp 1349 (WD Mich 1995).
97. Doe by Lavery v Attorney Gen'l, 44 F3d 715 (9th Cir 1995), superseded without opinion, 62 F3d 1424 (9th Cir), vacated and remanded sub nom Reno v Doe by Lavery, 116 SCt 2543 (1996).
98. Burris S. Prisons, law and public health: the case for a coordinated response to epidemic diseases behind bars. Univ Miami Law Rev. 1992;47:291-329.
99. Hetzel v Swartz, 917 F Supp 344 (MD Pa 1996).
100. Inmates of NY State With HIV v Cuomo, No. 90-CV-252, 1991 US Dist LEXIS 1488 (ND NY Feb 7, 1991).
101. Madrid v Gomez, 889 F Supp 1146 (ND Cal 1995).
102. State ex rel Peeples v Anderson, 653 NE2d 371 (Ohio 1995).
Table of Contents
Read the full text of the AIDS Litigation Project, Part I and Part II published by the AIDS and Public Policy Journal.
[ ] [JAMA HIV/AIDS Navigation Footer]
This site produced by the Journal of the American Medical Association.
© 1999 American Medical Association. All rights reserved.